Effects of Sprint Interval Training Versus Arabic Exercises BMI
Launched by RIPHAH INTERNATIONAL UNIVERSITY · Jun 11, 2024
Trial Information
Current as of July 25, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how two different types of exercise—sprint interval training (SIT) and aerobic exercise—affect women with polycystic ovary syndrome (PCOS), a condition that can cause irregular menstrual cycles, infertility, and other health issues. The goal is to see which exercise method is better at improving health markers, including body mass index (BMI) and overall quality of life for those with PCOS. Women aged 18 to 35 who have been diagnosed with PCOS and have a BMI of 25 or higher may be eligible to participate.
Participants in the trial will be randomly assigned to one of two groups. One group will do SIT, which involves short bursts of intense cycling followed by rest, three times a week. The other group will engage in moderate-intensity aerobic exercises like cycling or treadmill walking for the same duration. Throughout the study, researchers will measure changes in health markers and quality of life to determine the effects of each exercise type. This trial is important as it aims to provide better exercise recommendations for women with PCOS, which could help improve their health and well-being.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Diagnosed PCOS
- • Age: 18 - 35 years.
- • BMI ≥25 kg/m2
- • Unmarried females (5)
- • Oligomenorrhea
- • Irregular cycles (Have less than 9 periods in 1 year
- Exclusion Criteria:
- • Congenital adrenal hyperplasia, androgen-secreting tumors, and Cushing's syndrome
- • Cardiovascular diseases and thrombotic diseases.
- • Systemic illness (Acute or chronic hepatitis or nephritis, musculoskeletal and pulmonary disorder)
- • Taking medications known to affect ovarian function within the past 3 months.
- • Patients suffer from mental problems.
About Riphah International University
Riphah International University is a leading educational institution based in Pakistan, dedicated to advancing healthcare and medical research through innovative clinical trials. With a commitment to excellence in research and education, Riphah emphasizes ethical standards and scientific integrity in its clinical studies. The university collaborates with various stakeholders, including healthcare professionals and industry partners, to enhance patient outcomes and contribute to the global body of medical knowledge. Through its robust research programs, Riphah International University aims to foster a culture of inquiry and improve healthcare delivery both locally and internationally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Lahore, Punjab, Pakistan
Patients applied
Trial Officials
Sabiha Arshad, M.phill
Principal Investigator
Riphah International University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported